| Literature DB >> 31690760 |
Tzyy-Chang Ho1, Allen Yi-Lun Ho2, Muh-Shy Chen3,4,5.
Abstract
Differences in the pathogenesis and clinical characteristics between lamellar macular hole (LMH) with and without LMH-associated epiretinal proliferation (LHEP) can have surgical implications. This study investigated the effects of treating LHEP by foveolar internal limiting membrane (ILM) non-peeling and epiretinal proliferative (EP) tissue repositioning on visual acuity and foveolar architecture. Consecutive patients with LHEP treated at our institution were enrolled. The eyes were divided into a conventional total ILM peeling group (group 1, n = 11) and a foveolar ILM non-peeling group (group 2, n = 22). In group 2, a doughnut-shaped ILM was peeled, leaving a 400-μm-diameter ILM without elevated margin over the foveola after EP tissue repositioning. The EP tissue was elevated, trimmed, and inverted into the LMH. Postoperatively, the LMH was sealed in all eyes in group 2, with significantly better best-corrected visual acuity (-0.26 vs -0.10 logMAR; p = 0.002). A smaller retinal defect (p = 0.003), a more restored ellipsoid zone (p = 0.002), and a more smooth foveal depression (p < 0.001) were achieved in group 2. Foveolar ILM non-peeling and EP tissue repositioning sealed the LMH, released the tangential traction, and achieved better visual acuity. The presumed foveolar architecture may be reconstructed surgically. LMH with LHEP could have a combined degenerative and tractional mechanism.Entities:
Mesh:
Year: 2019 PMID: 31690760 PMCID: PMC6831694 DOI: 10.1038/s41598-019-52447-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic and clinical characteristics of patients with macular lamellar hole and LHEP who underwent conventional ILM total peeling versus foveolar ILM non-peeling with proliferative tissue repositioning surgery.
| Characteristic | Conventional ILM total peeling group (n = 11) | Foveolar ILM non-peeling with proliferative tissue repositioning group (n = 22) | |
|---|---|---|---|
| Age (years) | 67 ± 8.2 | 68 ± 9.0 | 0.285* |
| Female sex | 11 (72.7%) | 14 (70%) | 0.492† |
| Preoperative BCVA (logMAR) | 0.36 ± 0.25 | 0.38 ± 0.28 | 0.450* |
| Final BCVA (logMAR) | 0.26 ± 0.28 | 0.12 ± 0.15 | 0.003* |
| Change in BCVA (logMAR) | −0.10 ± 0.35 | −0.26 ± 0.22 | 0.002* |
| Intact preoperative ellipsoid zone (eyes) | 8 (72.7%) | 15 (68%) | 0.465† |
| Intact postoperative ellipsoid zone (eyes) | 8 (72.7%) | 21 (95%) | 0.002† |
| Preoperative retinal defect | 11 (100%) | 22 (100%) | 0.462† |
| Postoperative retinal defect | 6 (54.5%) | 1 (4.5%) | 0.003† |
| Preoperative smooth foveal depression | 0 (0%) | 0 (0%) | 1† |
| Postoperative smooth foveal depression | 1 (9%) | 19 (86.4%) | <0.001† |
| Postoperative macular hole formation | 0 (0%) | 0 (0%) | 1† |
| Follow-up duration (months) | 28.2 ± 8.2 | 29.3 ± 10.1 | 0.823† |
*Mann-Whitney U test; †Fisher’s exact test; ‡Independent samples t-test. BCVA, best-corrected visual acuity; LHEP, lamellar hole-associated epiretinal proliferation; ILM, internal limiting membrane; logMAR, logarithm of the minimum angle of resolution
Figure 1Case presentations. Figures 1-1–1-4 shows the case described in Fig. 4 and in the Supplementary Information). Figure 1-5A–1-5D shows a second case. The first was a 71-year-old man who had a lamellar macular hole (LMH) with lamellar hole-associated epiretinal proliferation (LHEP) in the right eye and a best-corrected visual acuity (BCVA) of 0.2 measured 2 years and 5 months preoperatively. The central foveal thickness (CFT) was 265 μm (1-1A, 1-1B). Epiretinal tissue is shown by the arrow. One month before surgery, a retinal defect was present (1-2A). The arrow shows the proliferative tissue. The BCVA had decreased to 0.1. The CFT had increased to 290 μm (1-2A, 1-2B). One month after foveolar internal limiting membrane (ILM) non-peeling and LHEP repositioning, the hole was well sealed with foveal depression (1-3A, 1-3B). The CFT was 317 μm. Three months postoperatively, the foveal depression was improved and the CFT had decreased to 258 μm (1-4A, 1-4B). The BCVA was improved to 0.8. The arrowheads mark the margin of the preserved ILM over the foveola (1-4A, 1-4B). The retinal defect was no longer present. A and B are horizontal and vertical optical coherence tomography scans, respectively. The second case (1-5A–1-5D) was a 56-year-old man who had LMH-associated epiretinal tissue with a disrupted ellipsoid zone (EZ) and external limiting membrane (arrowhead, 1-5A). He had a BCVA of 0.2 preoperatively. He underwent foveolar non-peeling internal limiting membrane (ILM) surgery with epiretinal tissue repositioning. Two months postoperatively, the LMH was well sealed with foveal depression, the EZ and external limiting membrane were growing toward the centre of the fovea, and there was a small retinal defect (arrowhead, 1-5B). The epiretinal proliferative tissue had been removed and the foveolar ILM was well preserved (the margins are marked by arrows, 1-5B). One further month later, the EZ and external limiting membrane has recovered almost completely and the retinal defect had disappeared (arrowhead, 1-5C). The BCVA improved to 0.4. Six months later, the BCVA improved to 1.0. The foveolar ILM was still well-preserved with a flat margin (arrows). The foveolar cone was restored gradually when compared with 1-5C with no retinal defect (1-5D). The EZ and external limiting membrane recovered (arrowhead).
Figure 2A 62-year-old woman with lamellar hole-associated epiretinal proliferative tissue and epiretinal membrane underwent pars plana vitrectomy with epiretinal tissue repositioning and total internal limiting membrane peeling. There was an outer retinal defect (arrowhead) and medium reflective epiretinal proliferative tissue (small arrows) before surgery (2-1A, 2-1B). Two years and 9 months postoperatively, there was a persistent outer retinal defect (arrowhead, 2-2A and 2-2B). The repositioned tissue was removed by total internal limiting membrane peeling, leaving a thin atrophic foveal structure (arrow). The medium reflective tissue in 2-1A was removed. A and B show horizontal and vertical optical coherence tomography scans at different time points.
Figure 4Serial photographs demonstrating the sequential surgical procedure of foveolar internal limiting membrane (ILM) non-peeling and epiretinal proliferative tissue repositioning surgery for epiretinal membrane and lamellar macular hole-associated epiretinal proliferative tissue. (A) Grasping the margin of the epiretinal membrane. (B) Starting to peel the epiretinal membrane over the lower margin (surgeon’s view). (C) Peeling the epiretinal membrane over the upper margin (surgeon’s view). (D) Completion of the peeling of the epiretinal membrane. (E) Initial trimming of the epiretinal membrane. (F) Tucking of the yellowish foveal tissue into the retinal cleavage. (G) Further trimming to an appropriate size. (H) Making a slit cut over the ILM. I. Peeling the upper part of the ILM in a circumferential manner (surgeon’s view). (J) Peeling to the lower part of the ILM (surgeon’s view). (K) Peeling the final part without elevation of the margin of the ILM. (L) A doughnut-shaped ILM is peeled off and the foveolar ILM is left over the foveola. The preserved foveolar margin of the ILM is shown by arrows.
Figure 3Schematic drawing of reconstruction of presumed Müller cell cones and foveolar architecture after foveolar internal limiting membrane non-peeling surgery in the case described in Fig. 1. (A) The orange outline denotes the Müller cell cones in the foveola originally described by Gass (1999) and Yamada (1969). (B) A postoperative OCT image of the case described in Fig. 1 without the Müller cell cones outlined. (C) A postoperative OCT image with the Müller cell cones outlined, highlighting reconstruction of Müller cell cones in the foveola. Mcc, Müller cell cones; g, ganglion cells; H, Henle’s fibres.